Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1016/j.clim.2021.108682

http://scihub22266oqcxt.onion/10.1016/j.clim.2021.108682
suck pdf from google scholar
33549831!7860942!33549831
unlimited free pdf from europmc33549831    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi

pmid33549831      Clin+Immunol 2021 ; 225 (?): 108682
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Common hematological values predict unfavorable outcomes in hospitalized COVID-19 patients #MMPMID33549831
  • Nunez I; Priego-Ranero AA; Garcia-Gonzalez HB; Jimenez-Franco B; Bonilla-Hernandez R; Dominguez-Cherit G; Merayo-Chalico J; Crispin JC; Barrera-Vargas A; Valdes-Ferrer SI
  • Clin Immunol 2021[Apr]; 225 (?): 108682 PMID33549831show ga
  • COVID-19 can range from asymptomatic to life-threatening. Early identification of patients who will develop severe disease is crucial. A number of scores and indexes have been developed to predict severity. However, most rely on measurements not readily available. We evaluated hematological and biochemical markers taken on admission and determined how predictive they were of development of critical illness or death. We observed that higher values of readily available tests, including neutrophil:lymphocyte ratio; derived neutrophil index; and troponin I were associated with a higher risk of death or critical care admission (P < 0.001). We show that common hematological tests can be helpful in determining early in the course of illness which patients are likely to develop severe forms, as well as allocating resources to those patients early, while avoiding overuse of limited resources in patients with reduced risk of progression to severe disease.
  • |*SARS-CoV-2/genetics[MESH]
  • |Adult[MESH]
  • |Biomarkers/*blood[MESH]
  • |Blood Cell Count[MESH]
  • |COVID-19/*blood/diagnosis/mortality/*virology[MESH]
  • |Cohort Studies[MESH]
  • |Disease Progression[MESH]
  • |Female[MESH]
  • |Hematologic Tests[MESH]
  • |Hospitalization[MESH]
  • |Humans[MESH]
  • |Male[MESH]
  • |Middle Aged[MESH]
  • |Polymerase Chain Reaction[MESH]
  • |Prognosis[MESH]
  • |Proportional Hazards Models[MESH]
  • |ROC Curve[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box